Nanomedicine Specialists are at the cutting edge of healthcare, utilizing nanotechnology to develop innovative treatments, diagnostic tools, and preventative measures. By working with particles on the nanometer scale (1-100 nanometers), these experts harness unique properties such as enhanced drug solubility, targeted delivery, and improved bioavailability. Nanomedicine offers the potential to create highly personalized therapies, particularly in the treatment of complex diseases like cancer, neurodegenerative conditions, and infections. Through their work, they aim to minimize side effects and maximize therapeutic effects, making treatments more effective and accessible. They also contribute to improving patient outcomes by tailoring treatments to individual genetic profiles, enhancing precision medicine.
These specialists are heavily involved in the design of advanced drug delivery systems, where nanoparticles are used to deliver medication directly to the targeted site, often reducing the need for invasive procedures and ensuring controlled release over time. Nanomedicine specialists also play a key role in the development of cutting-edge diagnostic techniques, including imaging tools that can detect diseases at the molecular level, which helps in early detection and more precise treatment planning. Collaborating closely with clinical researchers, engineers, and biologists, these experts are transforming theoretical nanotechnology into real-world medical solutions. As nanomedicine continues to evolve, these specialists remain integral to the ongoing advancement of modern healthcare.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia